How should costochondritis be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Costochondritis: Evaluation and Management

Costochondritis is a clinical diagnosis made by physical examination demonstrating reproducible chest wall tenderness over the costochondral junctions, and in most cases requires no imaging whatsoever. 1

Diagnostic Approach

Clinical Diagnosis

The diagnosis is straightforward in most patients:

  • Palpate the costochondral junctions (typically 3rd-7th ribs) and costosternal joints
  • Reproducible tenderness at these sites confirms the diagnosis
  • The condition accounts for approximately 42% of nontraumatic musculoskeletal chest wall pain 1

Risk Stratification for Cardiac Workup

Age and cardiac risk factors determine whether additional testing is needed:

  • Children, adolescents, and young adults (<35 years): History and physical examination alone are sufficient 2
  • Patients ≥35 years OR those with cardiac risk factors OR any cardiopulmonary symptoms: Obtain ECG and consider chest radiograph 2
  • Important caveat: Coronary artery disease is present in 3-6% of adult patients with chest pain AND chest wall tenderness, so don't be falsely reassured by reproducible tenderness alone in higher-risk patients 2

Imaging Recommendations

Chest radiography may be useful as initial imaging only when evaluating for specific alternative diagnoses (rib fracture, infection, neoplasm, pneumothorax), but is insensitive for costochondral abnormalities 1

Advanced imaging (CT, MRI, bone scan) is NOT indicated for uncomplicated costochondritis 1. Reserve these for:

  • Suspected infection (fever, purulent drainage, immunocompromised state)
  • Concern for malignancy
  • Failure to respond to appropriate treatment
  • Atypical presentations requiring exclusion of other pathology

Critical pitfall: Always consider infectious costochondritis or underlying malignancy in patients with persistent symptoms, systemic signs, or atypical features. Ultrasound before injection can detect unexpected masses 3.

Management

First-Line Treatment

The standard approach is conservative management with:

  • Acetaminophen or NSAIDs (where safe and appropriate) 2
  • Activity modification: Avoid movements that reproduce pain or cause chest muscle overuse 2
  • Reassurance: The condition is self-limited in most cases 2

Refractory Cases

For patients not responding to conservative measures:

Local corticosteroid injections provide symptomatic improvement in recalcitrant cases. In one study, all 13 patients treated with corticosteroid injections reported improvement 4

Stretching exercises show progressive significant pain reduction compared to controls (p<0.001) and can be a useful adjunct 5

Sulfasalazine may benefit patients with recurrent costochondritis: 10 of 11 patients with recurrent symptoms responded to this treatment 4

Prognosis and Follow-up

  • Most cases are self-limited and benign 2
  • At 1-year follow-up, approximately 55% of patients still report chest pain, but only one-third have definite persistent costochondritis 6
  • Early rheumatological review in persistent cases significantly reduces repeat admissions and unnecessary investigations 4

Red Flags Requiring Further Investigation

  • Fever or systemic symptoms (consider infectious costochondritis from organisms like Pseudomonas aeruginosa 7 or tuberculosis 8)
  • Progressive swelling or mass
  • Purulent drainage
  • Failure to improve with appropriate conservative treatment
  • Immunocompromised state or diabetes

Women and Hispanic patients have higher frequency of costochondritis presentation 6, though this doesn't change management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.